Search research articles
Contact Us
Filters
Showing results (181-190 of 202) with videos related to
Page
of 21
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
April 12, 2007
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection
Elena Sbrana, Robert Jordan, Dennis E Hruby, et al.
Antiviral Therapy
|
February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently
Sophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
The Journal of Infectious Diseases
|
July 9, 2018
Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
Andrew T Russo, Douglas W Grosenbach, Trevor L Brasel, et al.
Vaccine
|
January 30, 2008
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
Douglas W Grosenbach, Robert Jordan, David S King, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2012
SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity
James R Burgeson, Amy L Moore, Jordan K Boutilier, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects
Robert Jordan, Jarasvech Chinsangaram, Tove' C Bolken, et al.
Plos Biology
|
December 21, 2023
Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection
Bach Tran Nguyen, Aurélien Marc, Clara Suñer, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers
Jarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.
Plos Pathogens
|
February 22, 2024
Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods
Todd M Bell, Paul Facemire, Jeremy J Bearss, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans
Janet M Leeds, Frederique Fenneteau, Nathalie H Gosselin, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 202) with videos related to
Sort By:
Page
of 21
The American Journal of Tropical Medicine and Hygiene
|
April 12, 2007
Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection
Elena Sbrana, Robert Jordan, Dennis E Hruby, et al.
Antiviral Therapy
|
February 7, 2009
Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently
Sophie Duraffour, Solenne Vigne, Kurt Vermeire, et al.
The Journal of Infectious Diseases
|
July 9, 2018
Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques
Andrew T Russo, Douglas W Grosenbach, Trevor L Brasel, et al.
Vaccine
|
January 30, 2008
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination
Douglas W Grosenbach, Robert Jordan, David S King, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2012
SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity
James R Burgeson, Amy L Moore, Jordan K Boutilier, et al.
Antimicrobial Agents and Chemotherapy
|
April 14, 2010
Safety and pharmacokinetics of the antiorthopoxvirus compound ST-246 following repeat oral dosing in healthy adult subjects
Robert Jordan, Jarasvech Chinsangaram, Tove' C Bolken, et al.
Plos Biology
|
December 21, 2023
Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection
Bach Tran Nguyen, Aurélien Marc, Clara Suñer, et al.
Antimicrobial Agents and Chemotherapy
|
April 25, 2012
Pharmacokinetic comparison of a single oral dose of polymorph form i versus form V capsules of the antiorthopoxvirus compound ST-246 in human volunteers
Jarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.
Plos Pathogens
|
February 22, 2024
Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods
Todd M Bell, Paul Facemire, Jeremy J Bearss, et al.
Antimicrobial Agents and Chemotherapy
|
December 21, 2012
Pharmacokinetic and pharmacodynamic modeling to determine the dose of ST-246 to protect against smallpox in humans
Janet M Leeds, Frederique Fenneteau, Nathalie H Gosselin, et al.
Page
of 21